Latest TRxADE News
FDA Stay Informed RSS
- Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration May 26, 2019Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg, & 120 mg to the wholesale level. These products are being recalled as a precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA’s […]FDA
FiercePharma News RSS
- Novartis slaps $2M-plus price tag on newly approved gene therapy Zolgensma—and cost watchdogs approve May 24, 2019Industry watchers have been speculating for months about just how high Novartis would price gene therapy Zolgensma—and just how payers would cover the "transformative" spinal muscular atrophy treatment. Now, they have their answers.Carly Helfand
Leave a Reply
Want to join the discussion?Feel free to contribute!